HWAM
JAZZ icon

Hennion & Walsh Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hennion & Walsh Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Sell
48,019
-1,333
-3% -$292K 0.33% 53
2026
Q1 		$9.33M Buy
49,352
+1,817
+4% +$318K 0.31% 60
2025
Q4 		$8.08M Buy
47,535
+9,657
+25% +$1.48M 0.28% 65
2025
Q3 		$4.99M Buy
37,878
+986
+3% +$118K 0.18% 136
2025
Q2 		$3.91M Sell
36,892
-910
-2% -$98.9K 0.16% 155
2025
Q1 		$4.69M Buy
37,802
+1,908
+5% +$249K 0.21% 107
2024
Q4 		$4.42M Buy
35,894
+4,332
+14% +$511K 0.2% 116
2024
Q3 		$3.52M Buy
31,562
+2,115
+7% +$232K 0.16% 158
2024
Q2 		$3.14M Buy
29,447
+4,183
+17% +$460K 0.16% 155
2024
Q1 		$3.04M Buy
25,264
+4,445
+21% +$544K 0.16% 168
2023
Q4 		$2.56M Buy
20,819
+5,394
+35% +$673K 0.15% 206
2023
Q3 		$2M Buy
15,425
+3,208
+26% +$427K 0.13% 217
2023
Q2 		$1.51M Buy
12,217
+2,935
+32% +$395K 0.09% 277
2023
Q1 		$1.36M Buy
9,282
+702
+8% +$104K 0.08% 288
2022
Q4 		$1.37M Buy
8,580
+2,149
+33% +$315K 0.08% 276
2022
Q3 		$857K Buy
6,431
+841
+15% +$128K 0.06% 363
2022
Q2 		$872K Buy
5,590
+671
+14% +$103K 0.05% 349
2022
Q1 		$766K Sell
4,919
-208
-4% -$30.2K 0.04% 407
2021
Q4 		$653K Sell
5,127
-1,335
-21% -$175K 0.03% 471
2021
Q3 		$841K Sell
6,462
-227
-3% -$34.3K 0.04% 390
2021
Q2 		$1.19M Sell
6,689
-266
-4% -$46.1K 0.06% 327
2021
Q1 		$1.14M Buy
+6,955
New +$1.14M 0.07% 335

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Hennion & Walsh Asset Management's JAZZ Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.7% in Q2 2026, selling an estimated $292K and leaving 48,019 shares worth $11.6M. The position accounts for 0.33% of the portfolio, ranked #53.

Hennion & Walsh Asset Management first reported a position in JAZZ in Q1 2021 and has held it in 22 quarters since. 130 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Hennion & Walsh Asset Management held 48,019 shares of Jazz Pharmaceuticals worth $11.6M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 1,333 Jazz Pharmaceuticals shares in Q2 2026, an estimated $292K.
  • Jazz Pharmaceuticals made up 0.33% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #53 holding.
  • Hennion & Walsh Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 130 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.